健讯Daily|罗氏、优时比新药在华上市;亚太药业出售全资子公司兴亚药业100%股权

21世纪经济报道
01 Apr

政策动向  国家药监局征求《关于优化全生命周期监管支持高端医疗器械创新发展的举措(征求意见稿)》意见  3月31日,国家药监局综合司公开征求《关于优化全生命周期监管支持高端医疗器械创新发展的举措(征求意见稿)》意见。在选择部分领域高端医疗器械,研究提出支持创新发展的举措,经实地调研、座谈等方式听取意见建议后,形成该征求意见稿。药械审批  罗氏奥瑞利珠单抗上市申请获批  3月31日,罗氏宣布奥瑞利珠...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10